SynthesisJournal of the American Society of Nephrology : JASN2026
Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening.
Synthesis in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Prevalence and Diagnostic of Silent Ischemic Heart Disease in Polish Kidney Transplant Candidates.Journal of clinical medicine · 2026Article
- Cardiovascular Risk Assessment in Kidney Transplantation: Are We Asking the Right Questions?Journal of the American Society of Nephrology : JASN · 2026Article
- Rethinking Routine Coronary Screening in Kidney Transplant Candidates.Journal of the American Society of Nephrology : JASN · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
key pointsCoronary artery disease is a barrier to kidney transplantation. Many transplant programs mandate routine coronary artery disease screening. It remains unclear how many patients meet class 1 indication for revascularization. We conducted a meta-analysis to estimate the prevalence. Despite high frequency of screening, we found a relatively low prevalence of class 1 indication for coronary revascularization.
backgroundCardiovascular disease is the most common cause of morbidity and mortality in kidney transplant recipients. Screening for coronary disease is frequently required before kidney transplantation, but coronary intervention has not been shown to be beneficial except in complex coronary artery disease. The likelihood of finding significant coronary artery disease and the benefits of routine pretransplant screening are uncertain.
methodsWe performed a systematic review and meta-analysis. Medical Literature Analysis and Retrieval System Online and Excerpta Medica database were searched to identify manuscripts published between 1998 and 2024 reporting the results of pretransplant screening. The primary end points were the frequency of detecting significant coronary lesions for which there are American Heart Association class 1 indications for revascularization: ( 1 ) >50% left main stenosis or ( 2 ) multivessel disease with ejection fraction <35% during prekidney transplant screening. Secondary end points included frequency of detecting multivessel disease, proximal left anterior descending artery disease, and number of patients who underwent invasive coronary angiography. Meta-regression was used to explore outcome heterogeneity according to the presence of hypertension, diabetes, and age.
resultsWe identified 1273 studies, out of which 44 met eligibility criteria. The mean prevalence of class 1 indications was 2%, although the heterogeneity was high with estimates ranging from 0% to 17%. Estimated prevalence of proximal left anterior descending disease was 2% and left main stenosis was 1%, whereas 10% of patients had multivessel coronary artery disease, and 35% were referred for invasive angiography. There was no evidence of significant heterogeneity according to sex of the population or prevalence of diabetes or hypertension.
conclusionsIdentification of class 1 indications for revascularization during pretransplant coronary screening was rare. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2026_01_08_ASN0000000890.mp3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.